Ep Biocomposites Ltd
Fundamental Score
Ep Biocomposites Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of EPBIO across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Consistent Growth Track Record (83.96% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.
Strong Profit Growth Track Record (102.84% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Balanced Promoter Holding (70.05%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
6 factors identified
Profit Decline Concern (-57.14%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.
Revenue Contraction (-7.50%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions and competitive positioning. Monitor recovery strategies.
Weak Earnings Growth (0.41% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation. Consider growth catalysts and competitive positioning.
Negative Free Cash Flow (₹-7.51 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Ep Biocomposites Ltd
About EPBIO
Business Overview
EP Biocomposites Limited manufactures and sells fibre reinforced polymere products in India. The company offers bio-digester toilets, sewage and effluent treatment plants, fibre reinforced polymer (FRP) doors, fire doors, and laminated doors; and passive fire protection products, including fire rated cable coating system and electrical/plumbing shaft sealing. It also provides FRP allied products, such as FRP garden benches, security cabins, FRP dust bins, roof tiles, FRP toilets, FRP decorative trims, FRP frames, FRP hydrant doors, FRP dam doors, hydrant doors, and FRP machine and water meter covers. The company was founded in 1991 and is based in Panaji, India.
Company Details
Key Leadership
EPBIO Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Ep Biocomposites Ltd (EPBIO)?
As of 21 Jan 2026, 08:44 am IST, Ep Biocomposites Ltd (EPBIO) is currently trading at ₹90.00. The stock has a market capitalization of ₹17.78 (Cr).
Is EPBIO share price Overvalued or Undervalued?
EPBIO is currently trading at a P/E ratio of 19.33x, compared to the industry average of 20.29x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.
What factors affect the Ep Biocomposites Ltd share price?
Key factors influencing EPBIO's price include its quarterly earnings growth (Sales Growth: -7.50%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Ep Biocomposites Ltd a good stock for long-term investment?
Ep Biocomposites Ltd shows a 5-year Profit Growth of 102.84% and an ROE of 10.22%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.35 before investing.
How does Ep Biocomposites Ltd compare with its industry peers?
Ep Biocomposites Ltd competes with major peers in the Waste Management. Investors should compare EPBIO's P/E of 19.33x and ROE of 10.22% against the industry averages to determine its competitive standing.
What is the P/E ratio of EPBIO and what does it mean?
EPBIO has a P/E ratio of 19.33x compared to the industry average of 20.29x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹19 for every ₹1 of annual earnings.
How is EPBIO performing according to Bull Run's analysis?
EPBIO has a Bull Run fundamental score of 43.7/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does EPBIO belong to?
EPBIO operates in the Waste Management industry. This classification helps understand the competitive landscape and sector-specific trends affecting Ep Biocomposites Ltd.
What is Return on Equity (ROE) and why is it important for EPBIO?
EPBIO has an ROE of 10.22%, which shows decent profitability but room for improvement. Return on Equity measures how efficiently Ep Biocomposites Ltd generates profits from shareholders' equity.
How is EPBIO's debt-to-equity ratio and what does it indicate?
EPBIO has a debt-to-equity ratio of 0.35, which indicates moderate leverage that should be monitored. A ratio below 1.0 generally indicates conservative financing.
What is EPBIO's dividend yield and is it a good dividend stock?
EPBIO offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has EPBIO grown over the past 5 years?
EPBIO has achieved 5-year growth rates of: Sales Growth 83.96%, Profit Growth 102.84%, and EPS Growth 0.41%.
What is the promoter holding in EPBIO and why does it matter?
Promoters hold 70.05% of EPBIO shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is EPBIO's market capitalization category?
EPBIO has a market capitalization of ₹18 crores, placing it in the Small-cap category.
How volatile is EPBIO stock?
EPBIO has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for EPBIO?
EPBIO has a 52-week high of ₹N/A and low of ₹N/A.
What is EPBIO's operating profit margin trend?
EPBIO has a 5-year average Operating Profit Margin (OPM) of 14.48%, indicating the company's operational efficiency.
How is EPBIO's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of -7.50% and YoY Profit Growth of -57.14%.
What is the institutional holding pattern in EPBIO?
EPBIO has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.